Title21 Health Solutions
@title21hs.bsky.social
Delivering innovative, integrated software solutions for healthcare & life sciences since 2001. Driving compliance, efficiency & quality to enhance patient safety & care.
Title21 has joined the Blood and Cells Advocacy Roster (BCAR), supporting the advancement of blood and cell therapies through regulatory and compliance technology that helps blood centers streamline operations and expand patient access.
Read the full press release → pharmatimes.com/news/title21...
Read the full press release → pharmatimes.com/news/title21...
December 16, 2025 at 8:55 PM
Title21 has joined the Blood and Cells Advocacy Roster (BCAR), supporting the advancement of blood and cell therapies through regulatory and compliance technology that helps blood centers streamline operations and expand patient access.
Read the full press release → pharmatimes.com/news/title21...
Read the full press release → pharmatimes.com/news/title21...
Reflecting on an amazing time at ASH 2025! While celebrating the advancements, this quote from Dr. Sanam Loghavi hit home about the path ahead:
"Hematopathology lags behind every discipline across the board in adopting digital solutions."
The future is digital. Let's push for innovation!
"Hematopathology lags behind every discipline across the board in adopting digital solutions."
The future is digital. Let's push for innovation!
December 8, 2025 at 5:23 PM
Reflecting on an amazing time at ASH 2025! While celebrating the advancements, this quote from Dr. Sanam Loghavi hit home about the path ahead:
"Hematopathology lags behind every discipline across the board in adopting digital solutions."
The future is digital. Let's push for innovation!
"Hematopathology lags behind every discipline across the board in adopting digital solutions."
The future is digital. Let's push for innovation!
Happy Thanksgiving from Title21 Health Solutions!
This holiday season, we are reflecting on our profound gratitude for the biotherapy community and the daily strides being made to improve patient outcomes. Wishing you a wonderful and restorative day!
This holiday season, we are reflecting on our profound gratitude for the biotherapy community and the daily strides being made to improve patient outcomes. Wishing you a wonderful and restorative day!
November 26, 2025 at 4:33 PM
Happy Thanksgiving from Title21 Health Solutions!
This holiday season, we are reflecting on our profound gratitude for the biotherapy community and the daily strides being made to improve patient outcomes. Wishing you a wonderful and restorative day!
This holiday season, we are reflecting on our profound gratitude for the biotherapy community and the daily strides being made to improve patient outcomes. Wishing you a wonderful and restorative day!
Today is #WorldDiabetesDay. We're taking a moment to recognize the strength of the millions living with diabetes and the dedicated healthcare professionals who support them.
Sending our support to everyone working toward a healthier tomorrow.
#DiabetesCommunity #CellAndGeneTherapy
Sending our support to everyone working toward a healthier tomorrow.
#DiabetesCommunity #CellAndGeneTherapy
November 14, 2025 at 5:00 PM
Today is #WorldDiabetesDay. We're taking a moment to recognize the strength of the millions living with diabetes and the dedicated healthcare professionals who support them.
Sending our support to everyone working toward a healthier tomorrow.
#DiabetesCommunity #CellAndGeneTherapy
Sending our support to everyone working toward a healthier tomorrow.
#DiabetesCommunity #CellAndGeneTherapy
How do we scale autologous therapies without losing speed or safety?
Heather Purvis, Director of Clinical Operations at Title21, explores this question in the new BioProcess International eBook on supply chain scalability.
Download here → www.bioprocessintl.com/cell-therapi...
Heather Purvis, Director of Clinical Operations at Title21, explores this question in the new BioProcess International eBook on supply chain scalability.
Download here → www.bioprocessintl.com/cell-therapi...
November 12, 2025 at 6:00 PM
How do we scale autologous therapies without losing speed or safety?
Heather Purvis, Director of Clinical Operations at Title21, explores this question in the new BioProcess International eBook on supply chain scalability.
Download here → www.bioprocessintl.com/cell-therapi...
Heather Purvis, Director of Clinical Operations at Title21, explores this question in the new BioProcess International eBook on supply chain scalability.
Download here → www.bioprocessintl.com/cell-therapi...
We had a great time connecting with so many colleagues and partners at #AABB2025! The energy and focus on advancing biotherapy were incredible to see.
Our CEO, Tony Pare, has been attending for over 20 years and summed up the industry's momentum perfectly.
Our CEO, Tony Pare, has been attending for over 20 years and summed up the industry's momentum perfectly.
November 7, 2025 at 5:12 PM
We had a great time connecting with so many colleagues and partners at #AABB2025! The energy and focus on advancing biotherapy were incredible to see.
Our CEO, Tony Pare, has been attending for over 20 years and summed up the industry's momentum perfectly.
Our CEO, Tony Pare, has been attending for over 20 years and summed up the industry's momentum perfectly.
See Title21 Health Solutions at AABB 2025!
Discover how we're Accelerating Therapies from Collection to Care at Booth #1120.
🗓️ Schedule your meeting with the team: share.hsforms.com/2XOvGt1d1Rqa...
#AABB2025 #CellandGeneTherapy #StandardofCare #Manufacturing #Quality #Analytics
Discover how we're Accelerating Therapies from Collection to Care at Booth #1120.
🗓️ Schedule your meeting with the team: share.hsforms.com/2XOvGt1d1Rqa...
#AABB2025 #CellandGeneTherapy #StandardofCare #Manufacturing #Quality #Analytics
October 21, 2025 at 6:12 PM
See Title21 Health Solutions at AABB 2025!
Discover how we're Accelerating Therapies from Collection to Care at Booth #1120.
🗓️ Schedule your meeting with the team: share.hsforms.com/2XOvGt1d1Rqa...
#AABB2025 #CellandGeneTherapy #StandardofCare #Manufacturing #Quality #Analytics
Discover how we're Accelerating Therapies from Collection to Care at Booth #1120.
🗓️ Schedule your meeting with the team: share.hsforms.com/2XOvGt1d1Rqa...
#AABB2025 #CellandGeneTherapy #StandardofCare #Manufacturing #Quality #Analytics
Planning your agenda for the #AABB2025 Annual Meeting? Make sure to add Title21 Health Solutions to your list!
📍 Find us at Booth #1120
Skip the line and guarantee time with our team by scheduling a meeting today.
🗓️ Book a Meeting: share.hsforms.com/2XOvGt1d1Rqa...
📍 Find us at Booth #1120
Skip the line and guarantee time with our team by scheduling a meeting today.
🗓️ Book a Meeting: share.hsforms.com/2XOvGt1d1Rqa...
October 15, 2025 at 5:26 PM
Planning your agenda for the #AABB2025 Annual Meeting? Make sure to add Title21 Health Solutions to your list!
📍 Find us at Booth #1120
Skip the line and guarantee time with our team by scheduling a meeting today.
🗓️ Book a Meeting: share.hsforms.com/2XOvGt1d1Rqa...
📍 Find us at Booth #1120
Skip the line and guarantee time with our team by scheduling a meeting today.
🗓️ Book a Meeting: share.hsforms.com/2XOvGt1d1Rqa...
How can we build more resilient and cost-effective supply chains in the CGT space? ⛓️
Read the full article to see all the insights from our CCO, Jonathan Wofford, and Advisory Board Member Dr. Stella Vnook!
pharmasource.global/content/expe...
Read the full article to see all the insights from our CCO, Jonathan Wofford, and Advisory Board Member Dr. Stella Vnook!
pharmasource.global/content/expe...
How to Build Unbreakable Pharma Supply Chains
Industry leaders discuss how integrated supply planning between sponsors and CDMOs strengthens resilience and controls costs amid geopolitical pressures.
pharmasource.global
October 13, 2025 at 6:52 PM
How can we build more resilient and cost-effective supply chains in the CGT space? ⛓️
Read the full article to see all the insights from our CCO, Jonathan Wofford, and Advisory Board Member Dr. Stella Vnook!
pharmasource.global/content/expe...
Read the full article to see all the insights from our CCO, Jonathan Wofford, and Advisory Board Member Dr. Stella Vnook!
pharmasource.global/content/expe...
What a powerful conclusion to #MeetingOnTheMesa!
#MeetingOnTheMesa #DiscoveryOasis #Biotech #DigitalTransformation #CRISPR #PatientStory #CellTherapy #GeneTherapy
#MeetingOnTheMesa #DiscoveryOasis #Biotech #DigitalTransformation #CRISPR #PatientStory #CellTherapy #GeneTherapy
October 9, 2025 at 6:08 PM
What a powerful conclusion to #MeetingOnTheMesa!
#MeetingOnTheMesa #DiscoveryOasis #Biotech #DigitalTransformation #CRISPR #PatientStory #CellTherapy #GeneTherapy
#MeetingOnTheMesa #DiscoveryOasis #Biotech #DigitalTransformation #CRISPR #PatientStory #CellTherapy #GeneTherapy
Great takeaways from Meeting on the Mesa 2025 from CEO, Tony Pare, and CCO, Jonathan Wofford.
It's inspiring to see how collaboration, data, and technology are shaping the path forward for advanced therapies- we're proud to provide the digital backbone to support innovation from lab to patient.
It's inspiring to see how collaboration, data, and technology are shaping the path forward for advanced therapies- we're proud to provide the digital backbone to support innovation from lab to patient.
October 7, 2025 at 8:24 PM
Great takeaways from Meeting on the Mesa 2025 from CEO, Tony Pare, and CCO, Jonathan Wofford.
It's inspiring to see how collaboration, data, and technology are shaping the path forward for advanced therapies- we're proud to provide the digital backbone to support innovation from lab to patient.
It's inspiring to see how collaboration, data, and technology are shaping the path forward for advanced therapies- we're proud to provide the digital backbone to support innovation from lab to patient.
We're excited to be attending Meeting on the Mesa, happening right here in our hometown of Phoenix, next week!
If you'll be at the event, we'd love to connect! You can easily set up a time with Tony or Jonathan through the event app.
If you'll be at the event, we'd love to connect! You can easily set up a time with Tony or Jonathan through the event app.
October 1, 2025 at 5:51 PM
We're excited to be attending Meeting on the Mesa, happening right here in our hometown of Phoenix, next week!
If you'll be at the event, we'd love to connect! You can easily set up a time with Tony or Jonathan through the event app.
If you'll be at the event, we'd love to connect! You can easily set up a time with Tony or Jonathan through the event app.
We're heading to Boston! Our CEO Tony Pare and our CCO Jonathan Wofford, will be at the CAR-TCR Summit from September 23-26. Let's connect—schedule a meeting with them through the event app!
#CARTCR #CARTCR2025
#CARTCR #CARTCR2025
September 16, 2025 at 6:27 PM
We're heading to Boston! Our CEO Tony Pare and our CCO Jonathan Wofford, will be at the CAR-TCR Summit from September 23-26. Let's connect—schedule a meeting with them through the event app!
#CARTCR #CARTCR2025
#CARTCR #CARTCR2025
We brought the whole Title21 team, including our remote crew, to Phoenix for an All Employee meeting that was an absolute blast! Think collaboration, learning, and a delicious Italian cooking masterclass.
#TeamBuilding #TeamWork #CompanyCulture
#TeamBuilding #TeamWork #CompanyCulture
August 26, 2025 at 6:42 PM
We brought the whole Title21 team, including our remote crew, to Phoenix for an All Employee meeting that was an absolute blast! Think collaboration, learning, and a delicious Italian cooking masterclass.
#TeamBuilding #TeamWork #CompanyCulture
#TeamBuilding #TeamWork #CompanyCulture
Big shifts in cell & gene therapy (CGT) are forcing academic med centers to adapt fast.
Heather Purvis shares how funding cuts, staffing issues & outdated systems are reshaping the field.
🔗 Read more: themedicinemaker.com/issues/2025/...
#CGT #HealthcareInnovation #DigitalHealth #ClinicalOps
Heather Purvis shares how funding cuts, staffing issues & outdated systems are reshaping the field.
🔗 Read more: themedicinemaker.com/issues/2025/...
#CGT #HealthcareInnovation #DigitalHealth #ClinicalOps
Political Upheaval Forces Medical Centers to Adapt
Academic medical centers are racing to adapt as political turnover and funding uncertainty threaten the future of cell and gene therapy research.
themedicinemaker.com
August 6, 2025 at 8:02 PM
Big shifts in cell & gene therapy (CGT) are forcing academic med centers to adapt fast.
Heather Purvis shares how funding cuts, staffing issues & outdated systems are reshaping the field.
🔗 Read more: themedicinemaker.com/issues/2025/...
#CGT #HealthcareInnovation #DigitalHealth #ClinicalOps
Heather Purvis shares how funding cuts, staffing issues & outdated systems are reshaping the field.
🔗 Read more: themedicinemaker.com/issues/2025/...
#CGT #HealthcareInnovation #DigitalHealth #ClinicalOps
The future of Cell & Gene Therapy is efficient, safe, and accessible. But how do we get there? The answer lies in overcoming one of the industry's biggest hurdles: equipment management.
Read the article and checkout our infographic:
🔗 www.title21.com/streamlining...
Read the article and checkout our infographic:
🔗 www.title21.com/streamlining...
July 30, 2025 at 6:37 PM
The future of Cell & Gene Therapy is efficient, safe, and accessible. But how do we get there? The answer lies in overcoming one of the industry's biggest hurdles: equipment management.
Read the article and checkout our infographic:
🔗 www.title21.com/streamlining...
Read the article and checkout our infographic:
🔗 www.title21.com/streamlining...
Embracing a digital platform isn't just an upgrade; it's essential for scaling your work.
Read more about Title21's role➡️https://www.title21.com/streamlining-success-how-digital-solutions-are-revolutionizing-cgt-equipment-management/
#CGT #Pharma #BioTech #Innovation
Read more about Title21's role➡️https://www.title21.com/streamlining-success-how-digital-solutions-are-revolutionizing-cgt-equipment-management/
#CGT #Pharma #BioTech #Innovation
July 10, 2025 at 8:14 PM
Embracing a digital platform isn't just an upgrade; it's essential for scaling your work.
Read more about Title21's role➡️https://www.title21.com/streamlining-success-how-digital-solutions-are-revolutionizing-cgt-equipment-management/
#CGT #Pharma #BioTech #Innovation
Read more about Title21's role➡️https://www.title21.com/streamlining-success-how-digital-solutions-are-revolutionizing-cgt-equipment-management/
#CGT #Pharma #BioTech #Innovation
Title21's Jonathan Wofford joined Discover Pharma to discuss the future of CGT manufacturing, focusing on the crucial role of data and digital innovation.
See what Jonathan and other industry leaders had to say!
➡️ discover-pharma.com/unlocking-co...
#CGT #Pharma #Collaboration #Title21
See what Jonathan and other industry leaders had to say!
➡️ discover-pharma.com/unlocking-co...
#CGT #Pharma #Collaboration #Title21
July 8, 2025 at 7:10 PM
Title21's Jonathan Wofford joined Discover Pharma to discuss the future of CGT manufacturing, focusing on the crucial role of data and digital innovation.
See what Jonathan and other industry leaders had to say!
➡️ discover-pharma.com/unlocking-co...
#CGT #Pharma #Collaboration #Title21
See what Jonathan and other industry leaders had to say!
➡️ discover-pharma.com/unlocking-co...
#CGT #Pharma #Collaboration #Title21
Today is World Sickle Cell Day! Title21 stands in solidarity with the millions globally living with Sickle Cell Disease (SCD), a genetic blood disorder that profoundly impacts lives. Together, we can push for a future where SCD is no longer a life-limiting diagnosis.
#WorldSickleCellDay
#WorldSickleCellDay
June 19, 2025 at 6:43 PM
Today is World Sickle Cell Day! Title21 stands in solidarity with the millions globally living with Sickle Cell Disease (SCD), a genetic blood disorder that profoundly impacts lives. Together, we can push for a future where SCD is no longer a life-limiting diagnosis.
#WorldSickleCellDay
#WorldSickleCellDay
June is Cancer Survivors Month, a time to celebrate the victories won by patients every single day. Their stories are at the heart of everything we do at Title21. Today we celebrate every survivor and the hope they represent!
#CancerSurvivorsMonth
#CancerSurvivorsMonth
June 12, 2025 at 5:25 PM
June is Cancer Survivors Month, a time to celebrate the victories won by patients every single day. Their stories are at the heart of everything we do at Title21. Today we celebrate every survivor and the hope they represent!
#CancerSurvivorsMonth
#CancerSurvivorsMonth
Cell & Gene Therapy delivers hope, but manual equipment management causes delays & risks quality. Our new blog shows how digital solutions safeguard treatments & speed delivery to patients.
See the path forward: www.title21.com/streamlining...
#CGT #CellTherapy #PatientSafety #Biotech
See the path forward: www.title21.com/streamlining...
#CGT #CellTherapy #PatientSafety #Biotech
June 10, 2025 at 4:48 PM
Cell & Gene Therapy delivers hope, but manual equipment management causes delays & risks quality. Our new blog shows how digital solutions safeguard treatments & speed delivery to patients.
See the path forward: www.title21.com/streamlining...
#CGT #CellTherapy #PatientSafety #Biotech
See the path forward: www.title21.com/streamlining...
#CGT #CellTherapy #PatientSafety #Biotech
Cell & Gene Therapies (CGTs) are revolutionary, but their path from lab to patient is complex! Our new blog breaks down key challenges in processing & testing – and how to overcome them.
Check out the key takeaways below, then read the full post here: www.title21.com/overcoming-c...
Check out the key takeaways below, then read the full post here: www.title21.com/overcoming-c...
June 5, 2025 at 6:38 PM
Cell & Gene Therapies (CGTs) are revolutionary, but their path from lab to patient is complex! Our new blog breaks down key challenges in processing & testing – and how to overcome them.
Check out the key takeaways below, then read the full post here: www.title21.com/overcoming-c...
Check out the key takeaways below, then read the full post here: www.title21.com/overcoming-c...
Managing cell and gene therapies is a complex process. Labs must balance error reduction, compliance, and speed with quality. Our blog shows how software streamlines operations, boosting efficiency and delivering life-saving treatments faster. Read it here: www.title21.com/overcoming-c...
June 3, 2025 at 5:54 PM
Managing cell and gene therapies is a complex process. Labs must balance error reduction, compliance, and speed with quality. Our blog shows how software streamlines operations, boosting efficiency and delivering life-saving treatments faster. Read it here: www.title21.com/overcoming-c...
Clinics are eager to deliver life-saving #CGT treatments but face challenges—infrastructure gaps, training, and SOP alignment. The solution? Standardization + scalable support.
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
May 20, 2025 at 5:28 PM
Clinics are eager to deliver life-saving #CGT treatments but face challenges—infrastructure gaps, training, and SOP alignment. The solution? Standardization + scalable support.
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
Watch the full segment: ▶️ themedicinemaker.com/manufacture/...
#CellAndGeneTherapy #BioTherapies #HealthcareInnovation
Valuable perspectives on CGT safety from Title21's Heather Purvis on IBTV! Navigating new territory with patient safety first.
🔗Heather's Insights: www.title21.com/balancing-in...
#CellandGeneTherapy #CGT #PatientSafety #Innovation #ClinicalOperations #Title21HealthSolutions #IBTV
🔗Heather's Insights: www.title21.com/balancing-in...
#CellandGeneTherapy #CGT #PatientSafety #Innovation #ClinicalOperations #Title21HealthSolutions #IBTV
Balancing Innovation and Safety in CGT: Insights from Title21’s Heather Purvis - Title21 Health Solutions
As cell and gene therapies (CGTs) progress from the laboratory to patient care, clinical centers face unique challenges in adapting to these groundbreaking treatments. Explore insights from Title21’s ...
www.title21.com
May 14, 2025 at 5:47 PM
Valuable perspectives on CGT safety from Title21's Heather Purvis on IBTV! Navigating new territory with patient safety first.
🔗Heather's Insights: www.title21.com/balancing-in...
#CellandGeneTherapy #CGT #PatientSafety #Innovation #ClinicalOperations #Title21HealthSolutions #IBTV
🔗Heather's Insights: www.title21.com/balancing-in...
#CellandGeneTherapy #CGT #PatientSafety #Innovation #ClinicalOperations #Title21HealthSolutions #IBTV